Search results
Moderna’s flu-COVID combo shot hits goal in late-stage trial - Indianapolis Business Journal
Indianapolis Business Journal· 3 days agoModerna Inc. said its combination flu and COVID shot met the goals of a pivotal late-stage trial,...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 3 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 3 days agoModerna announced Monday that its combination COVID and flu vaccine showed positive results in a...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 3 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
Moderna, Inc. (NASDAQ:MRNA) Insider Sells $766,810.02 in Stock
ETF DAILY NEWS· 1 day agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 5,178 shares of the company’s stock in a transaction dated Monday, June 10th. Following the ...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 23 hours agoModerna has announced positive Phase III data for its Covid-19/influenza combination vaccine,...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna, Inc. (NASDAQ:MRNA) Director Sells $30,088,098.88 in Stock
ETF DAILY NEWS· 1 day agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 202,832 shares of the stock in a transaction that occurred on Tuesday, June 11th. The shares were ...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 1 day agoModerna price target raised at Oppenheimer after RSV vaccine approval